4-[(PYRIDIN-3-YLMETHYL)-AMINO]-BENZOIC ACID

Suppliers

Names

[ CAS No. ]:
62402-45-3

[ Name ]:
4-[(PYRIDIN-3-YLMETHYL)-AMINO]-BENZOIC ACID

Chemical & Physical Properties

[ Density]:
1.093g/cm3

[ Boiling Point ]:
383.9ºC at 760 mmHg

[ Molecular Formula ]:
C16H20ClNO2

[ Molecular Weight ]:
293.78900

[ Flash Point ]:
204.8ºC

[ Exact Mass ]:
293.11800

[ PSA ]:
44.48000

[ LogP ]:
4.44860

[ Index of Refraction ]:
1.569

Toxicological Information

CHEMICAL IDENTIFICATION

RTECS NUMBER :
SH8100000
CHEMICAL NAME :
Phenethylamine, 4-methoxy-alpha-(4'-methoxyphenyl)-, hydrochloride
CAS REGISTRY NUMBER :
62402-45-3
LAST UPDATED :
199112
DATA ITEMS CITED :
2
MOLECULAR FORMULA :
C16-H19-N-O2.Cl-H
MOLECULAR WEIGHT :
293.82
WISWESSER LINE NOTATION :
1OR DYZ1R DO1 &GH

HEALTH HAZARD DATA

ACUTE TOXICITY DATA

TYPE OF TEST :
LD50 - Lethal dose, 50 percent kill
ROUTE OF EXPOSURE :
Intravenous
SPECIES OBSERVED :
Rodent - rat
DOSE/DURATION :
50 mg/kg
TOXIC EFFECTS :
Details of toxic effects not reported other than lethal dose value
REFERENCE :
JPETAB Journal of Pharmacology and Experimental Therapeutics. (Williams & Wilkins Co., 428 E. Preston St., Baltimore, MD 21202) V.1- 1909/10- Volume(issue)/page/year: 77,317,1943
TYPE OF TEST :
LDLo - Lowest published lethal dose
ROUTE OF EXPOSURE :
Subcutaneous
SPECIES OBSERVED :
Rodent - mouse
DOSE/DURATION :
222 mg/kg
TOXIC EFFECTS :
Behavioral - tremor Behavioral - convulsions or effect on seizure threshold Behavioral - muscle contraction or spasticity
REFERENCE :
JAPMA8 Journal of the American Pharmaceutical Association, Scientific Edition. (Washington, DC) V.29-49, 1940-60. For publisher information, see JPMSAE. Volume(issue)/page/year: 39,354,1950

Safety Information

[ HS Code ]:
2922199090

Customs

[ HS Code ]: 2922199090

[ Summary ]:
2922199090. other amino-alcohols, other than those containing more than one kind of oxygen function, their ethers and esters; salts thereof. VAT:17.0%. Tax rebate rate:13.0%. . MFN tariff:6.5%. General tariff:30.0%

Related Compounds

  • 3-Amino-4-[(pyridin-3-ylmethyl)-amino]-benzoic acid
  • 4-[(Pyridin-3-ylmethyl)-amino]-benzoic acid methyl ester
  • 3-nitro-4-[(pyridin-3-ylmethyl)amino]benzoic acid
  • 3-METHYL-4-((PYRIDIN-3-YLMETHYL)AMINO)BENZOIC ACID
  • 4-[(2-Pyridinylcarbonyl)amino]benzoic acid
  • 4-METHOXY-3-((PYRIDIN-3-YLMETHYL)AMINO)BENZOIC ACID
  • 4-((Cyclohexylamino)methyl)benzoic acid hydrochloride
  • 1-[(2,4-Dichlorophenyl)methyl]-N-(1,1-dimethylethyl)-2-methyl-1H-indole-3-methanamine
  • 2-Methoxy-6-(pyrazol-1-yl)-benzonitrile
  • 1H-3-Benzazepin-7-ol, 8-chloro-2,3,4,5-tetrahydro-5-(3-iodophenyl)-3-methyl-, (S)-
  • 7-hydroxy-N-(4-iodophenyl)-5-oxo-2,3-dihydro-1H,5H-pyrido[3,2,1-ij]quinoline-6-carboxamide
  • 5-Bromo-2,4-dimethyl-1-[(2-methylindolinyl)sulfonyl]benzene
  • (4-Methyl-tetrahydro-furan-2-yl)-methanol
  • N-(1-cyanocyclopentyl)-2-[4-(4-fluorobenzenesulfonyl)-1,4-diazepan-1-yl]acetamide
  • 4,5,6,7-Tetrahydrobenzo[d]isoxazole-3-carbaldehyde
  • tert-Butyl-DL-alanine